Abstract
Colocalization of dopamine D1 (D1R) and D3 receptors (D3R) in specific neuronal populations suggests that their functional cross-talk might involve direct interactions. Here we report that the D1R coimmunoprecipitates with the D3R from striatal protein preparations, suggesting that they are clustered together in this region. Using bioluminescence resonance energy transfer (BRET2), we further suggest the existence of a physical interaction between D1R and D3R. Tagged D1R and D3R cotransfected in human embryonic kidney (HEK) 293 cells generated a significant BRET2 signal that was insensitive to agonist stimulation, suggesting that they form a constitutive heterodimer. D1R and D3R regulate adenylyl cyclase (AC) in opposite ways. In HEK 293 cells coexpressing D1R and D3R, dopamine stimulated AC with higher potency and displaced [3H]R-(+)-7-chloro-8-hydroxy-3-methyl-1-phenyl-2,3,4,5-tetrahydro-1H-3-benzazepine (SCH23390) binding with higher affinity than in cells expressing the D1R. In HEK 293 cells individually expressing D1R or D3R, agonist stimulation induces internalization of D1R but not of D3R. Heterodimerization with D3R abolishes agonist-induced D1R cytoplasmic sequestration induced by selective D1R agonists and enables internalization of the D1R/D3R complex in response to the paired stimulation of both D1R and D3R. This mechanism involves β-arrestin binding because it was blocked by mutant β-arrestinV53D. These data suggest that as a result of dimerization, the D3R is switched to the desensitization mechanisms typical of the D1R. These data give a novel insight into how D1R and D3R may function in an integrated way, providing a molecular mechanism by which to converge D1R- and D3R-related dysfunctions.
Footnotes
-
This study was supported by Ministero dell'Istruzione, dell'Università e della Ricerca and University of Brescia (PRIN 2006054175) and partially by Consiglio Nazionale delle Ricerche and Ministero dell'Istruzione, dell'Università e della Ricerca - Fondo Integrativo Speciale per la Ricerca (to C.M.) and partially by the Cariplo Foundation (grant 2006/0882/104878 to F.C. and grant 2006/0779/109251 to C.G.).
-
C.F. and C.B. contributed equally to this work.
-
ABBREVIATIONS: DA, dopamine; GFP, green fluorescent protein; Rluc, Renilla reniformis luciferase; GPCR, G protein-coupled receptor; GRK, G protein-coupled receptor kinase; PAGE, polyacrylamide gel electrophoresis; BRET2, bioluminescence resonance energy transfer; D1R, D1 receptor, D3R, D3 receptor; PBS, phosphate-buffered saline; HEK, human embryonic kidney; HRP, horseradish peroxidase; IP, immunoprecipitation; WB, Western blot; AC, adenylyl cyclase; l-DOPA, 3,4-dihydroxy-l-phenylalanine; LID, 3,4-dihydroxy-l-phenylalanine-induced dyskinesia; SCH23390, R-(+)-7-chloro-8-hydroxy-3-methyl-1-phenyl-2,3,4,5-tetrahydro-1H-3-benzazepine; HA, hemoagglutinin; buffer A, NaCl, EDTA, Na2HPO4, Nonidet P-40, and SDS; SKF 81297, (±)-6-chloro-7,8-dihydroxy-1-phenyl-2,3,4,5-tetrahydro-1H-3-benzazepine hydrobromide.
- Received November 27, 2007.
- Accepted April 17, 2008.
- The American Society for Pharmacology and Experimental Therapeutics
MolPharm articles become freely available 12 months after publication, and remain freely available for 5 years.Non-open access articles that fall outside this five year window are available only to institutional subscribers and current ASPET members, or through the article purchase feature at the bottom of the page.
|